| Multiple Sclerosis |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Antineoplastic Drug |
0 |
0.83 |
| Monoclonal Antibody |
0 |
0.83 |
| Disability |
0 |
0.32 |
| Glatiramer Acetate |
0 |
0.26 |
| Interferon Beta |
0 |
0.26 |
| Outpatient Clinic |
0 |
0.19 |
| Health Care Reform |
0 |
0.16 |
| Progressive Multifocal Leukoencephalopathy |
0 |
0.09 |
| Europe |
0 |
0.06 |
| JC Virus |
0 |
0.06 |
| Leukoencephalopathy |
0 |
0.06 |
| Multiple Sclerosis Treatment |
0 |
0.06 |
| Ohio |
0 |
0.06 |
| Relapsing Remitting Multiple Sclerosis |
0 |
0.06 |
| Student Health and Well-Being |
0 |
0.06 |
| Students |
0 |
0.06 |
| Medical Life |
0 |
0.05 |